While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type of shot that uses a more traditional vaccine-making technology, used by Novavax. The vaccine is generating interest among some ...

The newly updated COVID-19 vaccine just arrived in pharmacies and clinics nationwide, and a new poll suggests nearly half of people age 50 and older plan to get it. But some older adults with high risk of severe illness appear unlikely to seek the vaccine,

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.